Prime Medicine (PRME) Accumulated Expenses (2021 - 2026)

Prime Medicine has reported Accumulated Expenses for 6 years, with the latest figure at $8.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 11.89% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $8.1 million (down 11.89% YoY), and the FY2025 full-year result was $12.6 million, down 20.77% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $8.1 million, down from $12.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $18.7 million in Q3 2024, with the low at $300000.0 in Q2 2023.
• Historically, Accumulated Expenses has averaged $10.6 million across 5 years, with a median of $10.9 million in 2024.
• Annual changes were most pronounced in 2022 — Accumulated Expenses tumbled 71.26% — and 2024, when it jumped 3531.67%.
• Prime Medicine's Accumulated Expenses stood at $10.7 million in 2022, then surged by 32.02% to $14.1 million in 2023, then rose by 12.71% to $15.9 million in 2024, then declined by 20.77% to $12.6 million in 2025, then tumbled by 35.73% to $8.1 million in 2026.
• The last three Accumulated Expenses figures came in at $8.1 million (Q1 2026), $12.6 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.